Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic-Phase Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic-Phase Chronic Myeloid Leukemia

Published:2010-10-27 Issue:6 Volume:88 Page:809-813
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Takahashi N,Wakita H,Miura M,Scott S A,Nishii K,Masuko M,Sakai M,Maeda Y,Ishige K,Kashimura M,Fujikawa K,Fukazawa M,Katayama T,Monma F,Narita M,Urase F,Furukawa T,Miyazaki Y,Katayama N,Sawada K

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

2. Imatinib mesylate in the treatment of gastrointestinal stromal tumour

3. Clinical resistance to imatinib: mechanisms and implications

4. Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients

5. Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients;Cancer Chemotherapy and Pharmacology;2024-03-05

2. 新規高速液体クロマトグラフィ分析装置を用いたイマチニブ血中濃度定量の精度評価;YAKUGAKU ZASSHI;2023-11-01

3. Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology;Clinical Pharmacokinetics;2023-08-16

4. Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia;Pharmacology Research & Perspectives;2023-07-07

5. High throughput LC/ESI-MS/MS method for simultaneous analysis of 20 oral molecular-targeted anticancer drugs and the active metabolite of sunitinib in human plasma;Heliyon;2023-06